查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
蛋白质定序市场- 全球和区域分析：按产品和服务、按应用、按样本类型、按输入样本复杂性和读出复杂性、按技术、按最终用户、按地区- 分析和预测(2024) ~2033 )
市场调查报告书
商品编码
1592691

蛋白质定序市场- 全球和区域分析：按产品和服务、按应用、按样本类型、按输入样本复杂性和读出复杂性、按技术、按最终用户、按地区- 分析和预测(2024) ~2033 )

Protein Sequencing Market - A Global and Regional Analysis: Focus on Product, Technology, Application, End User, and Region - Analysis and Forecast, 2024-2033
出版日期: | 出版商: BIS Research | 英文 136 Pages | 商品交期: 1-5个工作天内

价格

蛋白质定序是确定蛋白质中胺基酸精确顺序的过程，对于理解蛋白质结构、功能和在生物系统中的作用至关重要。

它在生物技术、生物医学研究、药物发现和疾病诊断等领域发挥着重要作用。蛋白质定序为转译后修饰、蛋白质相互作用和疾病机制提供了宝贵的见解，促进了精准医学和标靶治疗的进步。

蛋白质定序的两种主要技术是埃德曼降解和质谱。 Edman 降解用于小蛋白质并依序去除胺基酸。另一方面，质谱分析由于其高通量和分析复杂样品的能力而被广泛用于大规模蛋白质体学。此外，这个市场还包括促进定序过程的设备、试剂和消耗品，以及为各行业提供蛋白质定序服务的受託研究机构。对生物标记发现和药物开发不断增长的需求继续推动该领域的创新。

主要市场统计数据
预测期 2024-2033
2024年评估 18.363 亿美元
2033年预测 26.97亿美元
复合年增长率 4.36%

全球蛋白质定序市场2023年初步估值为17.49亿美元，预计2033年将达26.97亿美元，复合年增长率高达4.36%，成长动能强劲。对个人化医疗的日益重视是蛋白质定序的主要驱动力。了解精确的氨基酸序列和蛋白质修饰对于识别生物标记和开发针对癌症、神经退化性疾病和心血管疾病等疾病的标靶治疗至关重要。蛋白质定序在药物发现中也至关重要，透过详细了解蛋白质结构，可以识别可作为药物标靶的蛋白质。生物製药公司利用序列资料开发生技药品，例如单株抗体和治疗性蛋白质。

随着技术进步不断提高蛋白质定序的准确性和可及性，这个市场正在彻底改变医疗保健服务，并正在全球范围内推动预防性和个人化医疗的时代。

该市场的产品包括质谱仪和定序等设备，以及蛋白质製备、消化和分析所需的试剂和耗材。这些工具对于研究人员进行准确、高通量的蛋白质定序至关重要。此外，受託研究机构和其他服务供应商在向生物製药公司、学术机构和实验室提供蛋白质定序服务方面发挥着重要作用。这些服务包括从蛋白质鑑定到复杂转译后修饰分析的一切。随着生物标记发现、个人化医疗和生物製药等领域应用的不断扩大，蛋白质定序市场对产品和服务的需求不断增加，尤其是在北美和亚太地区。

该报告考察了全球蛋白质定序市场，并按产品/服务、应用、样本类型、输入样本复杂性和读出复杂性、技术、最终用户和地区提供了市场概述。

目录

执行摘要

第一章全球蛋白质定序市场：概述

  • 趋势：当前和未来的影响评估
  • 蛋白质定序工作流程
  • 法律规范
  • 专利分析
  • 市场动态概览

第二章 全球蛋白质定序市场（按产品和服务），百万美元，2022-2033

  • 产品
  • 服务

第三章 全球蛋白质定序市场（按应用），百万美元，2022-2033

  • 生物製药
  • 基因工程
  • 其他的

第四章 全球蛋白质定序市场（依样本类型），百万美元，2022-2033

  • 生物检体
  • 组织样本
  • 培养细胞
  • 其他的

第五章 全球蛋白质定序市场（依输入样本复杂性和读出复杂性），百万美元，2022-2033

  • 输入样本复杂度
  • 读取复杂性

第六章 全球蛋白质定序序市场（依技术），百万美元，2022-2033

  • 质谱分析
  • 艾德曼劣化
  • 其他（单分子蛋白质序列分析等）

第 7 章 全球蛋白质定序市场（依最终使用者），百万美元，2022-2033

  • 学术机构与研究中心
  • 製药和 CRO
  • 生物技术、诊断和其他公司

第八章 全球蛋白质定序市场（按地区），百万美元，2022-2033

  • 区域概况
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 其他的

第九章 市场竞争状况

  • 全球蛋白质定序市场：竞争格局
  • 经营策略：2021年1月至2024年9月
  • 公司简介
    • Agilent Technologies, Inc.
    • Bioinformatics Solutions Inc.
    • Bio-Rad Laboratories, Inc.
    • Bruker Corporation
    • Charles River Laboratories International, Inc.
    • Creative Proteomics
    • FUJIFILM Holdings Corporation
    • Merck KGaA
    • Proteome Factory AG
    • Rapid Novor, Inc.
    • Seer, Inc.
    • Selvita SA
    • Shimadzu Corporation
    • Thermo Fisher Scientific, Inc.

第10章调查方法

Product Code: BHP1627SA

Introduction to Protein Sequencing

Protein sequencing is the process of determining the precise order of amino acids in a protein, which is crucial for understanding its structure, function, and role in biological systems. It plays an essential role in fields such as biotechnology, biomedical research, drug discovery, and disease diagnostics. Protein sequencing provides valuable insights into post-translational modifications, protein interactions, and disease mechanisms, enabling advancements in precision medicine and targeted therapies.

The two primary techniques for protein sequencing are Edman degradation and mass spectrometry. Edman degradation is used for smaller proteins, sequentially removing amino acids, while mass spectrometry is widely used for large-scale proteomics due to its high throughput and ability to analyze complex samples. Additionally, the market consists of instruments, reagents, consumables that facilitate the sequencing process, and contract research organizations providing protein sequencing services for various industries. The growing demand for biomarker discovery and drug development continues to drive innovations in this space.

KEY MARKET STATISTICS
Forecast Period2024 - 2033
2024 Evaluation$1,836.3 Million
2033 Forecast$2,697.0 Million
CAGR4.36%

Market Introduction

The global protein sequencing market, initially valued at $1,749.0 million in 2023, is poised for substantial growth, projected to reach $2,697.0 million by 2033, marking a remarkable compound annual growth rate (CAGR) of 4.36%. The growing emphasis on personalized medicine is a major driver for protein sequencing. Understanding the precise amino acid sequence and modifications of proteins is crucial for identifying biomarkers and developing targeted therapies for diseases such as cancer, neurodegenerative disorders, and cardiovascular conditions. Protein sequencing is also essential in drug discovery, where detailed knowledge of protein structures enables the identification of potential drug targets. Biopharmaceutical companies rely on sequencing data to develop biologics, such as monoclonal antibodies and therapeutic proteins.

As advancements in technology continue to enhance the accuracy and accessibility of protein sequencing, the market is primed to revolutionize healthcare delivery, ushering in an era of preventive and personalized medicine on a global scale.

Products in this market include instruments such as mass spectrometers and sequence and reagents and consumables essential for protein preparation, digestion, and analysis. These tools are vital for researchers to conduct precise, high-throughput protein sequencing. Additionally, contract research organizations and other service providers play a crucial role in offering protein sequencing services to biopharmaceutical companies, academic institutions, and research labs. These services encompass everything from protein identification to complex post-translational modification analysis. With growing applications in biomarker discovery, personalized medicine, and biopharmaceuticals, the demand for products and services in the protein sequencing market has been increasing, particularly in regions such as North America and Asia-Pacific.

Industrial Impact

The industrial impact of the protein sequencing market has been profound, significantly influencing various sectors, including healthcare, pharmaceuticals, biotechnology, and research. In the healthcare industry, protein sequencing enables the identification of biomarkers for early disease detection, leading to more precise diagnostics. It supports the development of personalized medicine, allowing for tailored treatments based on a patient's unique protein expression profile. In the manufacturing of biologics, ensuring protein integrity and sequence consistency is critical for maintaining product quality. Protein sequencing is used extensively in process optimization and quality control to monitor the purity and structural fidelity of proteins used in biopharmaceutical production. Moreover, the increasing use of sequencing in academic and clinical research has been driving scientific discoveries and expanding one's understanding of diseases and human biology. Overall, the integration of protein sequencing across these industries has fostered innovation, improved efficiency, and opened new avenues for economic growth and development. The integration of novel sequencing technologies and mass spectrometry has enhanced the scalability and precision of protein sequencing, increasing its industrial application across multiple sectors.

Market Segmentation

Segmentation 1: By Product and Service

  • Product
  • Service

Product Segment to Lead the Global Protein Sequencing Market (by Product and Service)

In the global protein sequencing market, as of 2023, the product segment held the largest share at 72.37%. This dominance can be attributed to the essential role of products such as mass spectrometry instruments and sample preparation reagents in the sequencing process.

Segmentation 2: By Application

  • Biotherapeutics
  • Genetic Engineering
  • Others

Biotherapeutics to Witness the Highest Growth between 2024 and 2033

Based on application, the global protein market was led by the biotherapeutics segment, which held a 69.51% share in 2023. Protein sequencing is crucial in developing and manufacturing biotherapeutics, including monoclonal antibodies, therapeutic proteins, and vaccines. Sequencing is essential for understanding protein structure, ensuring safety and efficacy, and optimizing manufacturing processes. This application area has been witnessing significant growth due to the rise of precision medicine and the increasing demand for targeted therapies in chronic diseases such as cancer, autoimmune disorders, and genetic conditions. The global burden of chronic diseases, particularly cancer, diabetes, and autoimmune diseases, has been pushing the demand for biotherapeutics, where protein sequencing plays a key role in the discovery and development of novel treatments.

Segmentation 3: By Sample Type

  • Biological Sample
  • Tissue Sample
  • Cultured Cell
  • Other Samples

Biological Samples Segment to Witness the Highest Growth between 2024 and 2033

Biological samples, which include a wide range of samples from living organisms (such as blood, urine, and saliva), are essential for various applications, including clinical diagnostics, drug development, and personalized medicine. The increasing demand for targeted therapies and personalized healthcare has been driving the growth of this segment. The development of advanced protein sequencing technologies, such as mass spectrometry and next-generation protein sequencing (NGS), has made it easier and more cost-effective to analyze biological samples in the near future.

Segmentation 4: By Technology

  • Mass Spectrometry
  • Edman Degradation
  • Other Technologies

Mass Spectrometry Segment to Occupy the Major Market Share between 2024 and 2033

In the protein sequencing market, the mass spectrometry segment will occupy the major market share between 2024 and 2033. Nevertheless, as next-generation sequencing technologies become more established and integrated into research workflows, they will shift market dynamics. Nanopore sequencing enables real-time sequencing of proteins and is particularly appealing due to its ability to provide long-read sequencing capabilities. Although still emerging, nanopore technology will enhance protein sequencing by providing insights into protein structure and interactions that mass spectrometry may not fully capture. This will also lead to increased collaboration and the development of hybrid approaches that leverage the strengths of both sequencing and mass spectrometry.

Segmentation 5: By End User

  • Academic Institutes
  • Pharma and CROs
  • Biotech, Diagnostics, and Other Companies

Academic Institutes Segment to Hold the Major Market Share between 2024 and 2033

In the global protein sequencing market, as of 2023, the academic institute segment held the largest share at 47.30%. The growth of the protein sequencing market has been fueled by rising investments in proteomics research. For example, Thermo Fisher's Quantitative Proteomics Research Grant Program provides up to $11,000 in mass spectrometry reagents to doctoral and post-doctoral students, promoting innovative research in quantitative proteomics. This initiative highlights private-sector support for academic research. Moreover, collaborations between academic institutions and biotech companies have been driving technological advancements, enhancing research capabilities, and broadening the market.

Segmentation 6: By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest-of-Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest-of-Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest-of-Latin America
  • Rest-of-the-World

The protein sequencing market in the North America region is expected to witness a significant growth rate of 3.81% during the forecast period, marked by the increasing demand for preventative medicine, clinical diagnostics, drug development, and biomarker discovery. However, the Asia-Pacific region is expected to reach $623.5 million in 2033 from $348.4 million in 2023, at a CAGR of 5.93% during the forecast period 2024-2033.

Recent Developments in the Protein Sequencing Market

  • In September 2024, GenNext Technologies and Agilent announced a collaboration for structural biology research for biopharmaceutical companies. The integration of GenNext's AutoFox Protein Footprinting System with Agilent's 6560 Ion Mobility Quadrupole Time-of-Flight Liquid Chromatography/Mass Spectrometry system is to be used for detailed protein structure analysis and biomolecular interaction studies.
  • In July 2024, Agilent acquired Sigsense, a company that developed AI-enabled lab operations technology assisting in enhancing and optimizing laboratory workflows.
  • In July 2024, Bioinformatics Solutions Inc. announced the release of PEAKS Studio 12 as part of the PEAKS 12 software generation. Leveraging the latest mass spectrometry technology, the offering advances research with proteomics solutions employing deep learning and innovative algorithms that support data analysis for peptide and protein identification and quantification.
  • In June 2024, Agilent announced advancements in GC/MS and LC/Q-TOF technology at the American Society for Mass Spectrometry 2024. The new HES 2.0 ion source provides atto-gram-level sensitivity along with a built-in intelligence system to streamline workflows.
  • In June 2024, Thermo Fisher Scientific introduced the Thermo Scientific Stellar mass spectrometer to advance clinical research.

Demand - Drivers, Challenges, and Opportunities

Market Demand Drivers:

Advancements in Computational Biology and Bioinformatics: Recent advancements in computational biology and bioinformatics have significantly influenced the protein sequencing market, particularly in drug discovery, proteomics research, and biomarker identification. These technologies utilize sophisticated algorithms, simulations, and extensive biological datasets to improve the design and analysis of protein sequences, thereby enhancing the accuracy and efficiency of sequencing methods.

Market Challenges:

Shortage of Skilled Labor: The protein sequencing process entails complex procedures that require a comprehensive understanding of biochemistry, molecular biology, and advanced analytical techniques. Skilled professionals are essential to operate sophisticated instruments, such as mass spectrometers, to ensure accurate and reliable data acquisition. Moreover, these experts must possess strong computational and bioinformatics capabilities to manage and interpret the substantial volumes of data generated during sequencing.

Market Opportunities:

Integration of Artificial Intelligence: The integration of artificial intelligence, particularly machine learning algorithms such as XGBoost, with protein sequencing technologies presents a significant opportunity to transform the field of molecular diagnostics and therapeutic decision-making. By employing novel materials, such as solid-state 2D phosphorene nanoslit devices, AI-enhanced models can significantly improve the accuracy and speed of amino acid identification at the single-molecule level, addressing long-standing challenges in high-throughput protein sequencing.

How can this report add value to an organization?

Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements and emerging applications in protein sequencing, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.

Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.

Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors' strengths and weaknesses and allowing them to strategize effectively to gain a competitive edge in the market.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • The base year considered for the calculation of the market size is 2023. A historical year analysis has been done for the period FY2020-FY2022. The market size has been estimated for FY2023 and projected for the period FY2024-FY2033.
  • The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report provides a market study of upstream and downstream products of protein.
  • The market contribution of the protein technologies anticipated to be launched in the future has been calculated based on the historical analysis of the solutions.
  • The company's revenue has been referenced from their annual reports for FY2022 and FY2023. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, market collaborations, and operational history.
  • The market has been mapped based on the available protein sequencing solutions. This report has considered and profiled all the key companies with significant offerings in this field.

Primary Research:

The primary sources involve industry experts in protein, including the market players offering products and services. Resources such as CEOs, vice presidents, marketing directors, and technology and innovation directors have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

  • Validation and triangulation of all the numbers and graphs
  • Validation of the report's segmentation and key qualitative findings
  • Understanding the competitive landscape and business model
  • Current and proposed production values of a product by market players
  • Validation of the numbers of the different segments of the market in focus
  • Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
  • Annual reports, SEC filings, and investor presentations of the leading market players
  • Company websites and detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles
  • Paid databases

The key data points taken from the secondary sources include:

  • Segmentations and percentage shares
  • Data for market value
  • Key industry trends of the top players of the market
  • Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

Profiled companies have been selected based on inputs gathered from primary experts, as well as analyzing company coverage, product portfolio, and market penetration.

The global protein sequencing market is driven by a diverse group of key players, each leveraging advanced technologies to meet the growing demand for accurate, high-throughput protein analysis. Some of the key players, including Thermo Fisher Scientific Inc., Agilent Technologies Inc., Bio-Rad Laboratories provide cutting-edge sequencing platforms, reagents and software. Further, the market also includes the presence of various service providers, such as Charles River Laboratories International, Inc. and Creative Proteomics, which have established a competitive advantage by offering tailored protein sequencing solutions, ranging from protein characterization to post-translational modifications.

Some prominent names established in this market are:

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc
  • Thermo Fisher Scientific, Inc.
  • Shimadzu Corporation
  • Charles River Laboratories
  • Selvita
  • Bruker Corporation
  • Merck KGaA
  • Seer, Inc.
  • FUJIFILM Holdings Corporation

Table of Contents

Executive Summary

Scope and Definition

1 Global Protein Sequencing Market: Overview

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Increasing Product Launches in the Market
    • 1.1.2 Growing Adoption of Single-Molecule Protein Sequencing
    • 1.1.3 High Demand for Biologics Development
  • 1.2 Workflow of Protein Sequencing
    • 1.2.1 Protein Sequencing Workflow Overview
  • 1.3 Regulatory Framework
    • 1.3.1 U.S.
      • 1.3.1.1 Regulatory Requirements for Protein Sequencing Products Intended as Medical Devices
      • 1.3.1.2 Regulatory Requirements for Research Use Only (RUO) Products
      • 1.3.1.3 Requirements under the Clinical Laboratory Improvement Amendments (CLIA) for Clinical Protein Sequencing Labs
    • 1.3.2 European Union (EU)
      • 1.3.2.1 Regulatory Requirements for Protein Sequencing Products Intended as Medical Devices
        • 1.3.2.1.1 EU Medical Device Regulation
        • 1.3.2.1.2 EU In Vitro Diagnostic Regulation
      • 1.3.2.2 Regulatory Requirements for Clinical Protein Sequencing Labs in the EU
    • 1.3.3 Japan
      • 1.3.3.1 Regulatory Requirements for Protein Sequencing Products Intended as Medical Devices
      • 1.3.3.2 Regulatory Requirements for Clinical Protein Sequencing Labs in Japan
    • 1.3.4 China
      • 1.3.4.1 Regulatory Requirements for Protein Sequencing Products Intended as Medical Devices
    • 1.3.5 Brazil
      • 1.3.5.1 Regulatory Requirements for Protein Sequencing Products Intended as Medical Devices
      • 1.3.5.2 Regulatory Requirements for Clinical Protein Sequencing Labs in Brazil
  • 1.4 Patent Analysis
    • 1.4.1 Patent Filing Trend (by Country)
    • 1.4.2 Patent Filing Trend (by Year)
  • 1.5 Market Dynamics Overview
    • 1.5.1 Market Drivers
      • 1.5.1.1 Advancements in Computational Biology and Bioinformatics in the Global Protein Engineering Market
      • 1.5.1.2 Expanding Applications in Research
      • 1.5.1.3 Technological Advancements in Protein Sequencing
    • 1.5.2 Market Restraints
      • 1.5.2.1 Shortage of Skilled Labour
      • 1.5.2.2 High Cost Hindering the Adoption of Protein Sequencing
    • 1.5.3 Market Opportunities
      • 1.5.3.1 Integration of Artificial Intelligence in Protein Sequencing

2 Global Protein Sequencing Market (by Product and Service), $Million, 2022-2033

  • 2.1 Product
    • 2.1.1 Instruments
    • 2.1.2 Reagents and Consumables
  • 2.2 Service

3 Global Protein Sequencing Market (by Application), $Million, 2022-2033

  • 3.1 Biotherapeutics
  • 3.2 Genetic Engineering
  • 3.3 Others

4 Global Protein Sequencing Market (by Sample Type), $Million, 2022-2033

  • 4.1 Biological Sample
  • 4.2 Tissue Sample
  • 4.3 Cultured Cell
  • 4.4 Other Samples

5 Global Protein Sequencing Market (by Input Sample Complexity and Readout Complexity), $Million, 2022-2033

  • 5.1 Input Sample Complexity
    • 5.1.1 Single Purified Proteins
    • 5.1.2 Multiplex Proteins
    • 5.1.3 Highly Complex Proteins
  • 5.2 Readout Complexity
    • 5.2.1 Simple Presence/Absence
    • 5.2.2 Expression Level
    • 5.2.3 Post-Translational Modifications (PTMs)
    • 5.2.4 Full Protein Sequence

6 Global Protein Sequencing Market (by Technology), $Million, 2022-2033

  • 6.1 Mass Spectrometry
  • 6.2 Edman Degradation
  • 6.3 Other Technologies (Single-Molecule Protein Sequencing and Others)

7 Global Protein Sequencing Market (by End User), $Million, 2022-2033

  • 7.1 Academic Institutes and Research Centers
  • 7.2 Pharmaceutical and CROs
  • 7.3 Biotechnology, Diagnostic, and Other Companies

8 Global Protein Sequencing Market (By Region), $Million, 2022-2033

  • 8.1 Regional Summary
  • 8.2 North America
    • 8.2.1 Regional Overview
    • 8.2.2 Driving Factors for Market Growth
    • 8.2.3 Factors Challenging the Market
    • 8.2.4 U.S.
    • 8.2.5 Canada
  • 8.3 Europe
    • 8.3.1 Regional Overview
    • 8.3.2 Driving Factors for Market Growth
    • 8.3.3 Factors Challenging the Market
    • 8.3.4 Germany
    • 8.3.5 U.K.
    • 8.3.6 France
    • 8.3.7 Italy
    • 8.3.8 Spain
    • 8.3.9 Rest-of-Europe
  • 8.4 Asia-Pacific
    • 8.4.1 Regional Overview
    • 8.4.2 Driving Factors for Market Growth
    • 8.4.3 Factors Challenging the Market
    • 8.4.4 China
    • 8.4.5 Japan
    • 8.4.6 India
    • 8.4.7 Australia
    • 8.4.8 South Korea
    • 8.4.9 Rest-of-Asia-Pacific
  • 8.5 Latin America
    • 8.5.1 Regional Overview
    • 8.5.2 Driving Factors for Market Growth
    • 8.5.3 Factors Challenging the Market
    • 8.5.4 Brazil
    • 8.5.5 Mexico
    • 8.5.6 Rest-of-Latin America
  • 8.6 Rest-of-the-World Protein Sequencing Market
    • 8.6.1 Regional Overview
    • 8.6.2 Driving Factors for Market Growth
    • 8.6.3 Factors Challenging the Market

9 Markets - Competitive Landscape

  • 9.1 Global Protein Sequencing Market: Competitive Landscape
    • 9.1.1 Corporate Strategies, January 2021-September 2024
    • 9.1.2 Partnerships, Alliances, and Business Expansions
    • 9.1.3 Mergers and Acquisitions
    • 9.1.4 Funding Activities
  • 9.2 Business Strategies, January 2021-September 2024
    • 9.2.1 Service/Product Launches
  • 9.3 Company Profiles
    • 9.3.1 Agilent Technologies, Inc.
      • 9.3.1.1 Overview
      • 9.3.1.2 Top Products
      • 9.3.1.3 Top Competitors
      • 9.3.1.4 Target Customers/End Users
      • 9.3.1.5 Analyst View
    • 9.3.2 Bioinformatics Solutions Inc.
      • 9.3.2.1 Overview
      • 9.3.2.2 Services Offered
      • 9.3.2.3 Top Competitors
      • 9.3.2.4 Target Customers/End Users
      • 9.3.2.5 Analyst View
    • 9.3.3 Bio-Rad Laboratories, Inc.
      • 9.3.3.1 Overview
      • 9.3.3.2 Top Products
      • 9.3.3.3 Top Competitors
      • 9.3.3.4 Target Customers/End Users
      • 9.3.3.5 Analyst View
    • 9.3.4 Bruker Corporation
      • 9.3.4.1 Overview
      • 9.3.4.2 Top Products
      • 9.3.4.3 Top Competitors
      • 9.3.4.4 Target Customers/End Users
      • 9.3.4.5 Analyst View
    • 9.3.5 Charles River Laboratories International, Inc.
      • 9.3.5.1 Overview
      • 9.3.5.2 Services Offered
      • 9.3.5.3 Top Competitors
      • 9.3.5.4 Target Customers/End Users
      • 9.3.5.5 Analyst View
    • 9.3.6 Creative Proteomics
      • 9.3.6.1 Overview
      • 9.3.6.2 Services Offered
      • 9.3.6.3 Top Competitors
      • 9.3.6.4 Target Customers/End Users
      • 9.3.6.5 Analyst View
    • 9.3.7 FUJIFILM Holdings Corporation
      • 9.3.7.1 Overview
      • 9.3.7.2 Top Products
      • 9.3.7.3 Top Competitors
      • 9.3.7.4 Target Customers/End Users
      • 9.3.7.5 Analyst View
    • 9.3.8 Merck KGaA
      • 9.3.8.1 Overview
      • 9.3.8.2 Top Products
      • 9.3.8.3 Top Competitors
      • 9.3.8.4 Target Customers/End Users
      • 9.3.8.5 Analyst View
    • 9.3.9 Proteome Factory AG
      • 9.3.9.1 Overview
      • 9.3.9.2 Services Offered
      • 9.3.9.3 Top Competitors
      • 9.3.9.4 Target Customers/End Users
      • 9.3.9.5 Analyst View
    • 9.3.10 Rapid Novor, Inc.
      • 9.3.10.1 Overview
      • 9.3.10.2 Services Offered
      • 9.3.10.3 Top Competitors
      • 9.3.10.4 Target Customers/End Users
      • 9.3.10.5 Analyst View
    • 9.3.11 Seer, Inc.
      • 9.3.11.1 Overview
      • 9.3.11.2 Top Products
      • 9.3.11.3 Top Competitors
      • 9.3.11.4 Target Customers/End Users
      • 9.3.11.5 Analyst View
    • 9.3.12 Selvita S.A.
      • 9.3.12.1 Overview
      • 9.3.12.2 Services Offered
      • 9.3.12.3 Top Competitors
      • 9.3.12.4 Target Customers/End Users
      • 9.3.12.5 Analyst View
    • 9.3.13 Shimadzu Corporation
      • 9.3.13.1 Overview
      • 9.3.13.2 Top Products
      • 9.3.13.3 Top Competitors
      • 9.3.13.4 Target Customers/End Users
      • 9.3.13.5 Analyst View
    • 9.3.14 Thermo Fisher Scientific, Inc.
      • 9.3.14.1 Overview
      • 9.3.14.2 Top Products
      • 9.3.14.3 Top Competitors
      • 9.3.14.4 Target Customers/End Users
      • 9.3.14.5 Analyst View

10 Research Methodology

  • 10.1 Data Sources
    • 10.1.1 Primary Data Sources
    • 10.1.2 Secondary Data Sources
    • 10.1.3 Data Triangulation
  • 10.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Protein Sequencing Market, $Million, 2024, 2028, and 2033
  • Figure 2: Global Protein Sequencing Market (by Region), $Million, 2023, 2027, and 2033
  • Figure 3: Global Protein Sequencing Market (by Product and Service), $Million, 2023, 2027, and 2033
  • Figure 4: Global Protein Sequencing Market (by Application), $Million, 2023, 2027, and 2033
  • Figure 5: Global Protein Sequencing Market (by Technology), $Million, 2023, 2027, and 2033
  • Figure 6: Global Protein Sequencing Market (by End User), $Million, 2023, 2027, and 2033
  • Figure 7: Key Events to Keep Track of in the Protein Sequencing Market
  • Figure 8: Protein Sequencing Workflow Overview
  • Figure 9: Number of Protein Sequencing Patents (by Country), January 2019-May 2024
  • Figure 10: Number of Protein Sequencing Patents (by Year), January 2019-May 2024
  • Figure 11: Impact Analysis of Market Navigating Factors, 2022-2033
  • Figure 12: Pipeline Involved in Protein Sequencing using Tandem Mass Spectrometry
  • Figure 13: Edman Degradation Protein Sequencing Workflow
  • Figure 14: Proteomics Literature Published in the U.S. (January 2020 to September 2024)
  • Figure 15: U.S. Protein Sequencing Market, $Million, 2022-2033
  • Figure 16: Canada Protein Sequencing Market, $Million, 2022-2033
  • Figure 17: Germany Protein Sequencing Market, $Million, 2022-2033
  • Figure 18: U.K. Protein Sequencing Market, $Million, 2022-2033
  • Figure 19: France Protein Sequencing Market, $Million, 2022-2033
  • Figure 20: Italy Protein Sequencing Market, $Million, 2022-2033
  • Figure 21: Spain Protein Sequencing Market, $Million, 2022-2023
  • Figure 22: Rest-of-Europe Protein Sequencing Market, $Million, 2022-2033
  • Figure 23: China Protein Sequencing Market, $Million, 2022-2033
  • Figure 24: Japan Protein Sequencing Market, $Million, 2022-2033
  • Figure 25: India Protein Sequencing Market, $Million, 2022-2033
  • Figure 26: Australia Protein Sequencing Market, 2022-2033
  • Figure 27: South Korea Protein Sequencing Market, $Million, 2022-2033
  • Figure 28: Rest-of-Asia-Pacific Protein Sequencing Market, $Million, 2022-2033
  • Figure 29: Brazil Protein Sequencing Market, $Million, 2022-2033
  • Figure 30: Mexico Protein Sequencing Market, $Million, 2022-2033
  • Figure 31: Rest-of-Latin America Protein Sequencing Market, $Million, 2022-2033
  • Figure 32: Corporate Strategies, January 2021- September 2024
  • Figure 33: Acquisitions (by Company), January 2021-September 2024
  • Figure 34: Funding Activities Share (by Company), January 2021-September 2024
  • Figure 35: Product Launches (by Company), January 2021-September 2024
  • Figure 36: Data Triangulation
  • Figure 37: Top-Down and Bottom-Up Approach
  • Figure 38: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Global Protein Sequencing Market Opportunities
  • Table 3: Product Launches, January 2023-September 2024
  • Table 4: Companies Providing Single-Molecule Protein Sequencing
  • Table 5: List of Molecular Targets Identified with Proteomics
  • Table 6: Major Protein Sequencing and Mass Spectrometry Service Fee
  • Table 7: Global Protein Sequencing Market (by Product and Service), $Million, 2022-2033
  • Table 8: Global Protein Sequencing Market, (by Product Type), $Million, 2022-2033
  • Table 9: Global Protein Sequencing Market (by Application), $Million, 2022-2033
  • Table 10: Global Protein Sequencing Market (by Sample Type), $Million, 2022-2033
  • Table 11: Global Protein Sequencing Market (by Input Sample Complexity), $Million, 2022-2033
  • Table 12: Global Protein Sequencing Market (by Readout Complexity), $Million, 2022-2033
  • Table 13: Global Single Protein Sequencing Market (by Readout Complexity), $Million, 2022-2033
  • Table 14: Global Multiplex Protein Sequencing Market (by Readout Complexity), $Million, 2022-2033
  • Table 15: Global Highly Complex Protein Sequencing Market (by Readout Complexity), $Million, 2022-2033
  • Table 16: Global Protein Sequencing Market (by Technology), $Million, 2022-2033
  • Table 17: Global Mass Spectrometry Protein Sequencing Market (by Input Sample Complexity), $Million, 2022-2033
  • Table 18: Global Mass Spectrometry Protein Sequencing Market (by Readout Complexity), $Million, 2022-2033
  • Table 19: Global Protein Sequencing Market (by End User), $Million, 2022-2033
  • Table 20: North America Protein Sequencing Market (by End User), $Million, 2022-2033
  • Table 21: North America Protein Sequencing Market (by Application), $Million, 2022-2033
  • Table 22: Europe Protein Sequencing Market (by End User), $Million, 2022-2033
  • Table 23: Europe Protein Sequencing Market (by Application), $Million, 2022-2033
  • Table 24: Asia-Pacific Protein Sequencing Market (by End User), $Million, 2022-2033
  • Table 25: Asia-Pacific Protein Sequencing Market (by Application), $Million, 2022-2033
  • Table 26: Latin America Protein Sequencing Market (by End User), $Million, 2022-2033
  • Table 27: Latin America Protein Sequencing Market (by Application), $Million, 2022-2033
  • Table 28: Rest-of-the-World Protein Sequencing Market (by End User), $Million, 2022-2033
  • Table 29: Rest-of-the-World Protein Sequencing Market (by Application), $Million, 2022-2033
  • Table 30: Partnerships, Alliances, and Business Expansions (by Company), January 2021-September 2024